Nazare
Julie-Anne Nazare, Lyon FR
Patent application number | Description | Published |
---|---|---|
20100196413 | Use of Yeast Flakes for Treating and/or Preventing Hyperinsulinemia - The invention relates to the use of yeast flakes for preparing a pharmaceutical composition for treating and/or preventing hyperinsulinemia. | 08-05-2010 |
Marc Nazare, Frankfurt DE
Patent application number | Description | Published |
---|---|---|
20080306056 | PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS - The present invention is directed to a compound of formula I, | 12-11-2008 |
20090203912 | Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles - The present invention relates to a process for the regioselective synthesis of compounds of the formula I, | 08-13-2009 |
Marc Nazare, Idstein DE
Patent application number | Description | Published |
---|---|---|
20080280946 | Azaindole-Derivatives As Factor Xa Inhibitors - Indazole-derivatives as factor Xa inhibitors The present invention relates to compounds of the formula I | 11-13-2008 |
Marc Nazare, Frankfurt Am Main DE
Patent application number | Description | Published |
---|---|---|
20130072493 | N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS - The present invention relates to N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides of the formula I, | 03-21-2013 |
20140288083 | N-[4-(1H-PYRAZOLO[3,4-B]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS - The present invention relates to N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides of the formula I, | 09-25-2014 |
20140357640 | N-[4-(1H-PYRAZOLO[3,4-B]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS - The present invention relates to N-[4-(1H-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides of the formula (I), (R2)n wherein Ar, R1, R2 and n have the meanings indicated in the claims. The compounds of the formula (I) are valuable pharmacologically active compounds which modulate protein kinase activity, specifically the activity of serum and glucocorticoid regulated kinase (SGK), in particular of serum and glucocorticoid regulated kinase isoform 1 (SGK-1, SGK1), and are suitable for the treatment of diseases in which SGK activity is inappropriate, for example degenerative joint disorders or inflammatory processes such as osteoarthritis or rheumatism. The invention furthermore relates to processes for the preparation of the compounds of the formula (I), their use as pharmaceuticals, and pharmaceutical compositions comprising them. | 12-04-2014 |
Mark Nazare, Idstein DE
Patent application number | Description | Published |
---|---|---|
20090069565 | NEW INDOLE DERIVATIVES AS FACTOR XA INHIBITORS - The present invention relates to compounds of formula I, | 03-12-2009 |